首页 | 本学科首页   官方微博 | 高级检索  
     

慢性阻塞性肺疾患稳定期舒利迭治疗的临床观察
引用本文:余美琼,罗再莲,邹文英. 慢性阻塞性肺疾患稳定期舒利迭治疗的临床观察[J]. 河北医学, 2012, 18(2): 205-207
作者姓名:余美琼  罗再莲  邹文英
作者单位:四川省自贡市第一人民医院板仓分院综合科,四川 自贡,643000
摘    要:目的:探讨慢性阻塞性肺疾患(COPD)稳定期应用舒利迭治疗的临床疗效.方法:随机将COPD稳定期96例患者分为观察组、对照组各48例.两组均给予异丙托溴铵、氨茶碱等常规治疗.观察组在该治疗基础上加用舒利迭治疗.结果:治疗3个月后,观察组治疗前后FEV、FEV1/FVC%及FEV1%预计值均有显著改善(P<0.05);对照组治疗前后各肺功能指标改善不明显.治疗后观察组FEV、FEV1/FVC%及FEV1%预计值改善优于对照组(P<0.05).治疗期间两组患者均无严重不良反应.结论:将舒利迭用于COPD稳定期治疗,患者肺功能显著改善,不良反应轻微,值得临床应用.

关 键 词:舒利迭  慢性阻塞性肺疾患  疗效

Clinical Observation of Seretide in Treatment of Chronic Obstructive Pulmonary Disease in Stabilization
YU Meiqiong , LUO Zailian , ZOU Wenying. Clinical Observation of Seretide in Treatment of Chronic Obstructive Pulmonary Disease in Stabilization[J]. Hebei Medicine, 2012, 18(2): 205-207
Authors:YU Meiqiong    LUO Zailian    ZOU Wenying
Affiliation:(The First People’s Hospital of Zigong,Sichuan Zigong 643000,China)
Abstract:Objective: To explore the clinical effect of seretide in treatment of chronic obstructive pulmonary disease in stabilization. Method:96 cases were divided into two groups,the observation group(n=48) and the control group(n=46).All cases were given the routine treatment including ipratmpium and aminophylline.The observation group were given by Seretide in addition. Result: The differences in FEV1,FEV1/FVC×100%and FEV1%were significant in the observation group before and after therapy(P<0.05).And they were significant in the control group before and after therapy(P<0.05).During the treatment period there’s no adverse reaction in two groups. Conclusion: Seretide can elevate the pulmonary function,with less adverse reaction,It’s worthy of clinical apply.
Keywords:Seretide  Chronic obstructive pulmonary disease  Effect
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号